Navigation Links
Shire Leads New Initiative to Reveal Challenges Facing Rare Disease Community
Date:11/19/2012

y that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal diseases and regenerative medicine as well as opportunities in other therapeutic areas to the extent they arise through acquisitions.  Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights.  Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing and commercialization of the Company's Specialty Pharmaceuticals, Human Genetic Therapies and Regenerative Medicine products, as well as the ability to secure new products for commercialization and/or development; government regulation of the Company's products; the Company's ability to manufacture its products in sufficient quantities to meet demand; the impact of competitive therapies on the Company's products; the Company's ability to register, maintain and enforce patents and other intellectual property rights relating to its products; the Company's ability to obtain and maintain government and other thi
'/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dr Steven Gillis to Join Shire Board of Directors
2. Shire Second Quarter Product Sales Up 16%
3. Shire Announces that the US Food and Drug Administration has Responded to its Citizen Petition for Adderall XR and has Approved One Abbreviated New Drug Application for Generic Adderall XR
4. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
5. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
6. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
7. Brain Cancer Research in Seattle Leads to New Treatment Options for Patients
8. Global Cables and Leads for Medical Equipment Industry
9. Top 100 Drug Sales Data Released - Plavix Leads the Way
10. DePuy & Transvaginal Mesh Lawsuit Settlement Funding Leads Legal-Bay to Banner 2nd Quarter
11. AIUM and AUA Guideline Development Leads To Practice Accreditation For Urologic Ultrasound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 27, 2015 /CNW/ - Export Development Canada (EDC) ... financing for Montreal,s Valeant Pharmaceuticals ... multinational pharmaceutical company. The loan is ... facility that Valeant is using to fund the repayment ... a leading gastrointestinal pharmaceutical company based in the US. ...
(Date:5/26/2015)...  The National Association of Boards of Pharmacy ® ... general availability for the .pharmacy domain begins June 3, ... may apply for .pharmacy domain names. The ... NABP has approved more than 300 .pharmacy domain names ... NABP created the .pharmacy TLD to provide consumers worldwide ...
(Date:5/26/2015)... 2015  AbbVie (NYSE: ABBV ) presented ... of its investigational, all-oral, interferon (IFN)- and ribavirin ... the Annual Meeting of the Japan Society of ... 1 GIFT-I evaluated genotype 1b (GT1b) chronic ... and without cirrhosis, who were either treatment-naïve or ...
Breaking Medicine Technology:EDC provides Valeant Pharmaceuticals with USD 67.5 M to support recent Salix Pharmaceuticals acquisition 2General Availability for .Pharmacy Domain Names Begins June 3, 2015 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 3AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 4AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 5AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 6
... ANGELES , Aug. 5 B. Braun Medical Inc. (B. Braun) ... gain premier access to customized, evidence-based drug libraries provided by the Zynx Health ... , , , ... , , , ...
... Aug. 5 Decision Resources, one of the ... healthcare issues, finds that, in first- and second-line treatment ... nearly 70 percent of surveyed infectious disease specialists and ... use Medarex/Merck,s CDA1 and CDB1, one year after the ...
Cached Medicine Technology:B. Braun Customers Gain Premier Access to Zynx Health Device Network's Evidence-based, Customizable Drug Library Program 2B. Braun Customers Gain Premier Access to Zynx Health Device Network's Evidence-based, Customizable Drug Library Program 3B. Braun Customers Gain Premier Access to Zynx Health Device Network's Evidence-based, Customizable Drug Library Program 4B. Braun Customers Gain Premier Access to Zynx Health Device Network's Evidence-based, Customizable Drug Library Program 5B. Braun Customers Gain Premier Access to Zynx Health Device Network's Evidence-based, Customizable Drug Library Program 6In First- and Second-Line Treatment of Clostridium Difficile Infection, Nearly 70 Percent of Surveyed Infectious Disease Specialists and Internists Will Use Fidaxomicin and Nearly Half Will Use CDA1/CDB1 2In First- and Second-Line Treatment of Clostridium Difficile Infection, Nearly 70 Percent of Surveyed Infectious Disease Specialists and Internists Will Use Fidaxomicin and Nearly Half Will Use CDA1/CDB1 3
(Date:5/26/2015)... Francisco, CA (PRWEB) May 27, 2015 ... and beautiful technology for women, today announces the ... that monitors women’s stress, sleep, activity and ovulation. ... jewelry with innovative health tracking technolo- gy, particularly ... stress levels, to provide women with lifestyle data ...
(Date:5/26/2015)... BROOK, Ill. (PRWEB) May 26, 2015 ... be an early marker of specific types of Alzheimer’s ... a new study published in the journal Radiology. ... Agosta, M.D., Ph.D., co-author of the study conducted at ... Milan, Italy. “However, white matter damage has a central ...
(Date:5/26/2015)... May 27, 2015 Visiting Nurse Association of ... at the American Cancer Society’s annual Relay for Life fundraiser. ... 12:00AM at Mennen Sports Arena, 161 East Hanover Ave, Morristown, ... the track to raise money and awareness to help the ... , According to the ACS, it is estimated that more ...
(Date:5/26/2015)... 2015 Securityhunter has been ... the United States Department of Health and Human Services ... The MATOC was awarded through the General Services Administration ... the PSC, which is a fee-for-service agency. The award ... options, and is an enterprise–wide physical security and security ...
(Date:5/26/2015)... ANGELES (PRWEB) May 27, 2015 Readers ... processes may find help in author Chester Litvin ... Psychoconduction : Litvin’s Code” (published by Trafford Publishing). , ... new approach for stimulating the brain. This book will ... to reeducate their sensory brain cells . He ...
Breaking Medicine News(10 mins):Health News:Bellabeat debuts the LEAF - smart jewelry that monitors women’s health. 2Health News:Bellabeat debuts the LEAF - smart jewelry that monitors women’s health. 3Health News:RSNA: Imaging Test May Identify Biomarker of Alzheimer’s Disease 2Health News:RSNA: Imaging Test May Identify Biomarker of Alzheimer’s Disease 3Health News:North Jersey Home Care Agency Supports Relay for Life Fundraiser 2Health News:Securityhunter Has Been Awarded a Multiple Award Task Order Contract (MATOC) by the Department of Health and Human Services 2Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 2Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 3
... , FRIDAY, Jan. 22 (HealthDay News) -- If you,re ready to ... potty training may be between the second and third birthdays. , ... window for moving your child out of diapers. Children who were ... incontinence -- daytime wetting and bed-wetting -- between ages 4 and ...
... physical and mental benefits as people grow old , FRIDAY, ... and gunning down bad guys might not sound like things ... , But they might want to start, some experts on ... have the potential to help seniors age more gracefully, keeping ...
... Drug Administration has approved the drug fampridine-SR for the treatment ... Medical Center (URMC) have been evaluating the effects of the ... the first medication shown to enhance some neurological functions in ... the way for today,s action by the FDA. ...
... Society report outlines 21 challenges and needs for global tobacco ... and expertise needed to reduce the rising tide of tobacco ... are the target of the multinational tobacco industry. The report ... issue of CA: A Cancer Journal for Clinicians . ...
... most women, having a baby is a joyful experience. But ... by grief, anxiety and depression. Global figures suggest that between ... first time are struck by depression. For the second birth, ... Kristin Akerjordet at the University of Stavanger in Norway, surveyed ...
... 2010) -- Weill Cornell Medical College has established a ... diverse and medically underserved communities in New York City. ... and Community Engagement (CEDREC) was created through an $8 ... and Health Disparities (NCMHD), a division of the National ...
Cached Medicine News:Health News: Potty Training Best Between Ages 2 and 3 2Health News: Potty Training Best Between Ages 2 and 3 3Health News: Potty Training Best Between Ages 2 and 3 4Health News:Video Gaming Just Might Fight Aging 2Health News:Video Gaming Just Might Fight Aging 3Health News:Researchers welcome new multiple sclerosis drug 2Health News:Researchers welcome new multiple sclerosis drug 3Health News:Global tobacco report outlines 21 challenges for 21st century 2Health News:Global tobacco report outlines 21 challenges for 21st century 3Health News:Emotions should be taken seriously 2Health News:Emotions should be taken seriously 3Health News:National Center on Minority Health and Health Disparities awards $8 million to Weill Cornell 2
... data for future generations. Most gels can be ... plate of our gel dryer, covering them with ... them to hold the cellophane flat. Tut's Tombs ... an open area somewhat larger than the gel ...
... Most gels can be dried by positioning them ... dryer, covering them with wet semi-permeable cellophane and ... cellophane flat. Tut's Tombs also produce great fluorographs. ... larger than the gel to be dried. Note ...
... Hoefer SE 1200 Easy Breeze Air Gel ... 25 cm or 24 gels 8 ... warm air temperatures for rapid drying, or no ... photograph or store smooth, transparent, dried gels. Add ...
... Gel Dryer : Dry up to 6 gels ... 10 cm without a vacuum pump. Choose ... no heat for controlled drying of problem gels. ... Add and remove gels at any time without ...
Medicine Products: